Seagen Inc.
SGENDelisted Dec 14, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001060736
Seagen Inc. was delisted on Dec 14, 2023; its insiders filed their last Form 4 on Dec 18, 2023; 614 institutions reported holding it in 13F filings for Q3 2023, worth $36.3B in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Seagen Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 534 | 6 | 574 | +46 |
| Shares | 166.5M | 28.6K | 166.0M | −451.5K (−0.3%) |
| Value | $21.4B | $3.67M | $33.6B | +$12.2B (+56.9%) |
6 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (132)
Institutions that held Seagen Inc. at the end of Q1 2023 but not at the end of Q4 2022.
Showing the largest 100 of 132 by value.
Sold out (86)
Institutions that held Seagen Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
Not filed for Q1 2023 yet (6)
Institutions that held Seagen Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Seeyond | 14,342 | $1.84M |
| Moser Wealth Advisors, LLC | 7,090 | $911.1K |
| Allstate Investment Management Co | 6,207 | $797.7K |
| Alpha Paradigm Partners, LLC | 851 | $109.0K |
| Sargent Bickham Lagudis LLC | 41 | $5.27K |
| CoreCap Advisors, LLC | 39 | $5.01K |